OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	289
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis	248
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis	243
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis	190
Psoriasis Prevalence in Adults in the United States	176
Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening	139
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis	124
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic	115
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	110
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine	107
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis	103
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis	96
Prevalence of Hidradenitis Suppurativa	91
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	86
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne	79
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis	78
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic	78
Systemic Immunomodulatory Treatments for Atopic Dermatitis	76
Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	74
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	74
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	70
Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	68
Association Between Medication Use and Bullous Pemphigoid	68
Evaluation of Sex-Specific Incidence of Melanoma	64
UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color	62

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy	62
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines	62
Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic	61
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders	60
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch	59
Secukinumab Therapy for Netherton Syndrome	58
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis	58
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride	57
Enanthem in Patients With COVID-19 and Skin Rash	57
Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19	56
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab	56
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic	55
Prognostic Gene Expression Profiling in Cutaneous Melanoma	55
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children	52
Association Between Atopic Eczema and Cancer in England and Denmark	51
Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US	49
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	49
Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases	48
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis	45
Association Between Adult Acne and Dietary Behaviors	45
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures	44
Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy	44
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma	43
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection	43
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy	42
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis	42
Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris	42
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis	41
Evaluation of Cyclosporine for the Treatment of DRESS Syndrome	40
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma	39
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017	38
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare	38
Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	37
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome	37
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US	36
Prevalence of Vitiligo Among Adults in the United States	36
Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States	36
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients	36
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	35
Hidradenitis Suppurativa in the Pediatric Population	35
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort	35
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis	35
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis	34
Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19	34
Surgical Interventions for Patients With Vitiligo	34
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	33
Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors	32
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer	32
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis	32
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary	32

Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa	32
Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma	31
Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood	31
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma	30
Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting	29
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage	29
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	29
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis	29
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	29
Administrative Burden and Costs of Prior Authorizations in a Dermatology Department	28
Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome	28
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis	28
Multidisciplinary and Holistic Models of Care for Patients With Dermatologic Disease and Psychosocial Comorbidity	28
Association Between Melanoma Detected During Routine Skin Checks and Mortality	28
Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System	28
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	27
Incidence and Prevalence of Granuloma Annulare in the United States	26
Machine Learning–Based Deep Phenotyping of Atopic Dermatitis	26
Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice	26
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States	26
Focus on “COVID Toes”	26
Incidence of and Factors Associated With Leprosy Among Household Contacts of Patients With Leprosy in Brazil	26
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis	25
Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus	25
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis	25
Assessment of Changes in Diversity in Dermatology Clinical Trials Between 2010-2015 and 2015-2020	25
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis	25
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis	25
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance	24
Association of Multiple Aggregated Yellow-White Globules With Nonpigmented Basal Cell Carcinoma	24
Time-Dependent Risk of Acute Myocardial Infarction in Patients With Alopecia Areata in Korea	24
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection	24
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis	24
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients	24
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic	24
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea	23
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis	23
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer	23
Twitter Journal Clubs	23
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma	23
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus	23
How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic	22
Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis	22
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US	22
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis	22
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis	22
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases	22
Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid	22
Effect of a Face-Aging Mobile App–Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil	22
Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989	22
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities	21
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)	21
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris	21
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States	21
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer	21
The Genomic and Phenotypic Landscape of Ichthyosis	21
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma	20
Treatment of Kimura Disease With Dupilumab	20
Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort	20
Mycosis Fungoides in Children and Adolescents	19
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis	19
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum	19
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum	19
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma	19
Disease Trajectories for Hidradenitis Suppurativa in the Danish Population	19
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma	19
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy	19
Long-term Outcomes and Prognosis in New-Onset Psoriasis	19
Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19	19
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid	19
Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus	19
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma	19
The Multidimensional Burden of Atopic Dermatitis Among Adults	18
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms	18
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States	18
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	18
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity	18
Association of Atopic Dermatitis Severity With Learning Disability in Children	18
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa	18
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)	18

Changes in Disease Activity and Damage Over Time in Patients With Morphea	18
Association of Spironolactone Use With Risk of Cancer	17
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	17
Association of Lipid-Lowering Drugs With Risk of Psoriasis	17
Evaluation of Pharmacologic Treatments for H₁ Antihistamine–Refractory Chronic Spontaneous Urticaria	17
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy	17
Evaluation of Stigma Toward Individuals With Alopecia	17
Differences Between Children and Adults With Hidradenitis Suppurativa	17
Association of Inflammation With Progression of Hair Loss in Women With Frontal Fibrosing Alopecia	17
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population	17
Postmarketing Cases of Enfortumab Vedotin–Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis	17
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis	17
Association Between Atopic Dermatitis and Educational Attainment in Denmark	17
Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits	17
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	17
Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion	16
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency	16
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris	16
Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea	16
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	16
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	16
Dermatologists’ Perspectives on Artificial Intelligence and Augmented Intelligence — A Cross-sectional Survey	16
Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis	16
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis	16
Association of Sensorineural Hearing Loss in Patients With Alopecia Areata	16
Central Centrifugal Cicatricial Alopecia	16
Trends of Research Output of Allopathic Medical Students Matching Into Dermatology, 2007-2018	16
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	16
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	16
Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study	16
Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection	16
Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata	15
FrontlineBRAFTesting–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies	15
Clinically Applicable Deep Learning Framework for Measurement of the Extent of Hair Loss in Patients With Alopecia Areata	15
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017	15
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	15
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis	15
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	15
An Evaluation of the Performance of Current Morphea Subtype Classifications	15
Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study	15
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid	15
Epidermolysis Bullosa Pruriginosa Treated With Baricitinib	15
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus	15
Health Insurance Coverage of Permanent Hair Removal in Transgender and Gender-Minority Patients	15
Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease	15
Patient Perspectives on the Use of Artificial Intelligence	14
Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center	14
A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne	14
Chronic Pain in Hidradenitis Suppurativa Explained Through the Process of Central Sensitization	14
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults	14
Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid	14
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)	14
An Approach to Examining Tightly Coiled Hair Among Patients With Hair Loss in Race-Discordant Patient-Physician Interactions	14
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe	14
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	14
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	14
Treatment of Oral Erosive Lichen Planus With Upadacitinib	13
Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone	13
Sexual and Gender Minority Curricula Within US Dermatology Residency Programs	13
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita	13
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images	13
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma	13
Shared Decision-making in Dermatology	13
The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV	13
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis	13
Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children	13
Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment	13
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	13
Legislative Efforts Restricting Care for Transgender People	13
A Mutational Survey of Acral Nevi	13
Isotretinoin Laboratory Monitoring in Acne Treatment	12
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years	12
Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US	12
Pathogenesis-Based Therapy With Repurposed Biologics for Monogenic Inflammatory Skin Disorders	12
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis	12
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	12
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors	12
Keloids	12
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis	12
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis	12
Risks of Multiple Skin Cancers in Organ Transplant Recipients	12
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis	12
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome	12
Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa	12
Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata	11
Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa Surgery	11
Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome–Toxic Epidermal Necrolysis Spectrum Disease	11
Mapping of Segmental and Partial Segmental Infantile Hemangiomas of the Face and Scalp	11
Skin Cancer Risk Factors and Screening Among Asian American Individuals	11
Improvement of Chronic Kidney Disease–Associated Pruritus After Treatment With Intravenous Naloxone	11
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	11
Risk of Mortality After a Diagnosis of Melanoma In Situ	11
Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa	11
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma	11
Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States	11